Allergan, Inc. Press Releases

AGN 
$162.375
*  
0.265
0.16%
Get AGN Alerts
*Delayed - data as of Aug. 29, 2014 9:49 ET  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    AGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Allergan to Request California Federal Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading Laws
8/26/2014 7:53:00 PM - Business Wire

Allergan Receives Written Requests from Pershing Square Regarding Special Meeting of Stockholders
8/22/2014 6:55:00 PM - Business Wire

Pershing Square Submits Requisite Requests from Allergan Shareholders to Call Special Meeting
8/22/2014 6:28:00 PM - Business Wire

Beauty School is In Session -- Create a No-Makeup, Makeup Look
8/20/2014 8:30:00 AM - PR Newswire

Nearly Half of Women in New Survey Reveal that Their Current Treatments are Not Adequately Addressing Overactive Bladder (OAB) Symptoms
8/19/2014 8:30:00 AM - PR Newswire

Allergan Names Jim Hindman Chief Financial Officer
8/18/2014 9:00:00 AM - Business Wire

Valeant Extends Offer To Acquire Allergan
8/15/2014 5:00:00 PM - PR Newswire

Aegon Delivers Strong Q2 2014 Results
8/14/2014 1:30:00 AM - PR Newswire

Allergan Acquires LiRIS® Program from TARIS Biomedical®
8/13/2014 4:30:00 PM - Business Wire

Aegean Provides Market Update on Chilean Exploration Projects
8/12/2014 6:15:00 AM - Market Wire

Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
8/11/2014 5:30:00 PM - PR Newswire

Allergan Receives Second Request from Federal Trade Commission Regarding Valeant’s Unsolicited Acquisition Proposal
8/11/2014 12:50:00 PM - Business Wire

Institutional Shareholder Services (ISS) Recommends Allergan Shareholders Call A Special Meeting Of Shareholders
8/6/2014 3:04:00 PM - PR Newswire

Allergan Comments on ISS and Glass Lewis Recommendations
8/6/2014 12:55:00 PM - Business Wire

Aegean Provides Market Update on Turkish Exploration Projects
8/6/2014 9:42:00 AM - Market Wire

Glass Lewis & Co. Recommends Allergan Shareholders Support Pershing Square’s Effort to Call a Special Meeting of Shareholders
8/5/2014 9:52:00 AM - Business Wire

Allergan Comments on Valeant’s Second Quarter 2014 Earnings Results
8/5/2014 8:00:00 AM - Business Wire

Allergan R&D Innovations Recognized with Three Nominations for the 2014 U.S. Prix Galien Awards
8/4/2014 9:00:00 AM - Business Wire

Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit
8/1/2014 3:01:00 PM - PR Newswire

Allergan Files Lawsuit in Federal Court against Valeant and Pershing Square for Violations of Federal Securities Laws
8/1/2014 11:30:00 AM - Business Wire

Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Receives European Positive Opinion for the Treatment of Diabetic Macular Edema
7/25/2014 7:55:00 AM - Business Wire

Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements
7/24/2014 8:00:00 AM - PR Newswire

Allergan Reports Second Quarter 2014 Operating Results
7/21/2014 8:00:00 AM - Business Wire

Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements
7/21/2014 7:13:00 AM - PR Newswire

Allergan Announces Quarterly Conference Call
7/18/2014 12:00:00 PM - Business Wire